Utilizing novel fluorothymidine PET imaging in a phase I study of veliparib on an intermittent and continuous schedule given in combination with carboplatin in metastatic breast cancer
Robert Wesolowski, Daniel G. Stover, Maryam B. Lustberg, Abigail Shoben, Meng Zhao, Ewa Mrozek, Rachel M. Layman, Erin Macrae, Wenrui Duan, Jun Zhang, Nathan Hall, Chadwick L. Wright, Katharina Schregel, Susan Gillespie, Michael Berger, Andrea Camp, Jeffrey J. Chalmers, Priya Balasubramanian, Brandon L. Miller, Peter Amaya, Eleni Andreopoulou, Joseph Sparano, Charles L. Shapiro, Miguel Angel Villalona-Calero, Susan Geyer, Alice Chen, Michael R. Grever, Michael V Knopp, Bhuvaneswari Ramaswamy
medRxiv 2020.01.20.20018218; doi: https://doi.org/10.1101/2020.01.20.20018218